NUTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Nutex Health Inc (NUTX) is not a strong buy for a beginner, long-term investor at this time. The technical indicators do not show a clear upward trend, and the financial performance, despite revenue growth, is overshadowed by a significant decline in net income and EPS. Additionally, there are no significant positive catalysts or trading signals to suggest immediate action.
The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 28.014, and moving averages are converging, showing no clear trend. The stock is trading near its S1 support level of 101.169, but there is no strong indication of a reversal.
Revenue increased significantly by 239.87% YoY in Q3 2025, and gross margin improved by 107.87%.
Net income dropped by -730.78% YoY, and EPS fell by -551.16% YoY. No recent news or significant insider/hedge fund activity to drive the stock upward.
In Q3 2025, revenue increased to $267.8M (+239.87% YoY), but net income dropped to $55.4M (-730.78% YoY), and EPS fell to 7.76 (-551.16% YoY). Gross margin improved to 57.83% (+107.87% YoY).
No analyst rating or price target changes available.
